3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
5
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
mCRC
1
RAS Wild Type mCRC
1
Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Carcinoma
1
Interventions
trifluridine tipiracil drug combination
1
Cetuximab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
mCRC
×
Cetuximab
×
Clear all
NCT07543471
2026-04-24
PK similarity
Shanghai Henlius Biotech
Phase 1
Not yet recruiting
387 enrolled